The global coronavirus pandemic has killed more than 806,000 people worldwide, nearly a quarter of those in the United States.
More than 23.2 million people internationally have been diagnosed with COVID-19, the disease caused by the new respiratory virus, according to knowledge compiled through the Center for Science and Systems Engineering at Johns Hopkins University. Actual figures are thought to be much higher due to a shortage of checks, unreported instances, and suspicions that some national governments hide or minimize the scope of their epidemics.
The United States is the worst-affected country, with more than 5.6 million cases diagnosed and at least 176,659 deaths.
The town of Tuscaloosa, Alabama, will close its bars from 6 p.m. Monday after the University of Alabama reported an increase in COVID-19 cases.
Mayor Walter Maddox signed an executive order prohibiting all bars from serving alcohol until September 8; violating the order may be fined or sentenced to up to 180 days in municipal jail.
In a letter to academics on Sunday, university president Stuart Bell called the increase in campus instances “unacceptable” and said it was a “critical moment” for the school.
“Make no mistake, this trend is a genuine risk to our ability throughout the semester on campus,” Bell said, adding that “violations of our fitness and protection protocols” are “subject to serious disciplinary action, up to additional suspension. “University.
The Tuscaloosa University Police and Police Department will monitor off-campus bars, restaurants and apartments where orders are followed.
ABC News’ Janice McDonald contributed to the report.
New York Gov. Andrew Cuomo said the state’s infection rate by COVID-19 0.66% on Sunday, the lowest since the pandemic began.
“It’s a day,” Cuomo said at Monday’s press conference, noting that the state has had an infection rate of less than 1% for more than two weeks.
However, the western component of the state, adding the Buffalo area, has noticed an increase in cases and infection rates, he said.
The U.S. Environmental Protection Agency announced Monday that it granted emergency approval for the first surface antiviral coating approved for use to permanently oppose COVID-19’s guilty virus with a bachelor application.
The product, SurfaceWise 2, from Allied BioScience of Texas, is now approved for use through American Airlines, Texas Methodist Health Group and at some locations at Texas Total Orthopaedics Sports and Spine clinics.
“This is, I think, a major announcement of our efforts to combat coronavirus and COVID19,” EPA administrator Andrew Wheeler said in a call with reporters Monday morning.
While the product is intended to deactivate the virus on surfaces between regimen cleanings for up to seven days, Wheeler said he did not intend to update the common cleaning with disinfectants, hand washing, masked dress or social estrangement. He also claimed that the EPA did not discover any fitness hazards when it came into contact with the product on a surface, the National Institutes of Health found that the main ingredient, quaternary ammonium, can be irritating and exacerbate asthma.
ABC News’ Stephanie Ebbs contributed to this report.
The University of Hong Kong claims to have documented the first global case of coVID-19 reinfection.
The university made the announcement in a press release Monday, revealing the effects of her exam on a “seemingly young and healthy patient” who had a momentary episode of COVID-19 infection that was diagnosed more than 4 months after the first episode. A team of researchers showed that the viral strain genome series in the first episode of COVID-19 infection is “clearly different” from that of the viral strain discovered at the time of the infection episode, according to the press release.
Last week, the World Health Organization said more than 75,000 COVID-19 sequences were known and would like to see evidence of inflamed Americans with two other sequences to produce reinfection.
Dozens of studies on COVID-19 immunity are being conducted worldwide. So far, WHO officials say they have learned that other people are having an immune reaction to the virus, but it is not yet clear how strong this reaction is and how long it lasts.
“What we perceive from the press is that this” can “be an example of reinfection,” said Dr Maria van Kerkhove, WHO COVID-19 technical officer and infectious disease epidemiologist, at Monday’s press conference in Geneva.
“It is very vital that we document this and in the countries where sequencing can be done, it would be very, very useful,” he added. “But we will have to not jump to conclusions, even if this is the first documented case of reinfection.”
Christine Theodorou and Karson Yiu of ABC News contributed to the report.